Paper Details
- Home
- Paper Details
Double-blind controlled study of methazolamide in the treatment of essential tremor.
Author: BusenbarkK, HopfenspergerK, HubbleJ, KollerW, PahwaR, PogrebraK
Original Abstract of the Article :
We studied the effect of the carbonic anhydrase inhibitor methazolamide in 25 patients with essential tremor (ET) in a double-blind, placebo-controlled trial. Tremor assessment included patient self-reporting of functional disability, clinical rating of motor tasks and tremor severity, and accelerom...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1212/wnl.43.5.1045
データ提供:米国国立医学図書館(NLM)
Methazolamide for Essential Tremor: A Double-Blind Study
This study investigates the effectiveness of methazolamide, a carbonic anhydrase inhibitor, in treating essential tremor (ET). The researchers conducted a double-blind, placebo-controlled trial to determine whether methazolamide could provide relief from the tremors that characterize this condition. They assessed tremor severity using various measures, including patient self-reporting, clinical rating scales, and accelerometry.
Limited Efficacy of Methazolamide for Essential Tremor
This study, like a camel searching for a mirage in the desert, reveals that methazolamide does not offer a significant benefit for treating essential tremor. The researchers found no substantial difference in tremor severity between the methazolamide and placebo groups, suggesting that this medication is unlikely to be an effective treatment option for ET.
Navigating Essential Tremor Treatment: Finding the Right Path
The study highlights the importance of considering various treatment options for essential tremor and carefully evaluating their effectiveness. It underscores the need for ongoing research to develop more effective and safe therapies for this common neurological condition.
Dr. Camel's Conclusion
This study, like a desert traveler who discovers a dead end, reveals that methazolamide is not the answer for essential tremor. It underscores the importance of exploring alternative treatment options and continuing research to find effective therapies for this debilitating condition.
Date :
- Date Completed 1993-06-11
- Date Revised 2019-05-14
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.